Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
9.55B | 9.45B | 9.49B | 10.11B | 9.39B | 7.84B | Gross Profit |
1.73B | 1.73B | 1.65B | 1.95B | 1.94B | 1.39B | EBIT |
383.90M | 338.90M | 205.60M | 535.10M | 497.00M | 61.10M | EBITDA |
569.40M | 501.90M | 494.50M | 780.20M | 795.70M | 267.60M | Net Income Common Stockholders |
162.00M | 131.30M | -35.40M | 196.40M | 250.00M | -220.50M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
623.20M | 793.30M | 767.70M | 644.50M | 770.70M | 1.07B | Total Assets |
7.41B | 7.55B | 7.77B | 7.95B | 7.89B | 7.34B | Total Debt |
3.27B | 3.31B | 3.57B | 3.60B | 3.66B | 3.68B | Net Debt |
2.65B | 2.52B | 2.80B | 2.95B | 2.89B | 2.61B | Total Liabilities |
5.63B | 5.79B | 6.10B | 6.29B | 6.44B | 6.24B | Stockholders Equity |
1.78B | 1.75B | 1.68B | 1.66B | 1.45B | 1.09B |
Cash Flow | Free Cash Flow | ||||
136.00M | 167.00M | 101.20M | -1.60M | 495.70M | -79.20M | Operating Cash Flow |
171.10M | 208.00M | 152.20M | 49.10M | 549.50M | -38.20M | Investing Cash Flow |
112.60M | 81.20M | 48.90M | -120.70M | -749.50M | -257.80M | Financing Cash Flow |
-221.80M | -253.40M | -120.80M | -79.30M | -65.80M | 571.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $10.99B | 20.69 | 8.16% | ― | 13.63% | 78.40% | |
76 Outperform | $38.90B | 39.19 | 12.15% | ― | 13.14% | 1.70% | |
74 Outperform | $2.40B | 14.80 | 9.53% | ― | 1.24% | 1205.18% | |
67 Neutral | $1.26B | ― | -6.44% | 2.49% | 6.69% | -137.52% | |
60 Neutral | $2.82B | 10.29 | 0.31% | 8508.26% | 5.91% | -17.42% | |
58 Neutral | $2.14B | 29.46 | 5.32% | 1.03% | 13.87% | 90.42% | |
53 Neutral | $1.14B | ― | -1.09% | 1.70% | 14.79% | 82.32% |
On May 15, 2025, Cushman & Wakefield held its annual general meeting where shareholders approved several key proposals. These included the election of directors, ratification of KPMG LLP as the independent auditor, and approval of executive compensation plans. The decisions reflect the company’s ongoing governance and strategic planning efforts, impacting its operational and financial oversight.
The most recent analyst rating on (CWK) stock is a Hold with a $12.00 price target. To see the full list of analyst forecasts on Cushman & Wakefield stock, see the CWK Stock Forecast page.
Spark’s Take on CWK Stock
According to Spark, TipRanks’ AI Analyst, CWK is a Outperform.
Cushman & Wakefield earns a solid score of 74, driven by a combination of robust financial performance, positive earnings momentum, and a fair valuation. The company’s strategic leverage reduction and consistent revenue growth stand out as key strengths, while technical indicators suggest potential short-term gains despite a longer-term bearish trend. Challenges in EMEA leasing highlight areas for improvement but do not significantly detract from the overall positive outlook.
To see Spark’s full report on CWK stock, click here.
On March 28, 2025, Cushman & Wakefield announced a proposal to change its jurisdiction of incorporation from England and Wales to Bermuda. This redomiciliation aims to reduce administrative burdens and align corporate governance with the expectations of its U.S. shareholder base. The company assures that this move will have limited impact on its operations, subsidiaries, and financial statements, maintaining its commitment to its businesses in the U.K. and Europe. The redomiciliation process requires shareholder approval and is expected to be completed in the second half of 2025.